{
  "main_header": {
    "sid": 10039033,
    "name": "Valiant Laborato",
    "stock_name": "Valiant Laborato",
    "full_name": "Valiant Laboratories Ltd",
    "name_url": "stocks-analysis/valiant-laborato",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "68.98",
    "chg": 1.03,
    "chgp": "1.52%",
    "dir": 1,
    "prev_price": "67.95",
    "mcapval": "369.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543998,
    "symbol": "VALIANTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0JWS01017",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "31.12 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/valiant-laborato-10039033-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 263,
    "sid": "10039033",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/valiant-laboratories-10039033"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "30-May-2026",
      "details": "Please find enclosed",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "22-May-2026",
      "details": "Annual Secretarial Compliance Report for the Financial Year 2025-2026.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011",
      "datetime": "20-May-2026",
      "details": "The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Valiant Organics Ltd",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Laboratories Ltd has announced <strong>1:4</strong> rights issue, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

No Recent News for the Company

View All News